Intercalated Administration of PamCis With Gefitinib or Placebo as First Line Lung Adenocarcinoma in Never Smokers
Clinical trial NCT01502202 · UNKNOWN
Trial details
- NCT number
- NCT01502202
- Sponsor
- National Cancer Center, Korea
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-01
- Primary completion
- 2014-08-01
- Enrollment
- 162
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.